Publications

A global dataset of publicly available dengue case count data.

Clarke, J; LIM, A; Gupte, P; Pigott, DM; Van Panhuis, WG; BRADY, OJ;

2024

Scientific Data, (2024).11 1 10.1038/s41597-024-03120-7.

Long-term healthcare utilisation, costs and quality of life after invasive group B <i>Streptococcus</i> disease: a cohort study in five low-income and middle-income countries.

Seedat, F; PROCTER, S; Dangor, Z; Leahy, S; Santhanam, S; John, HB; Bassat, Q; Aerts, C; Abubakar, A; Nasambu, C; Libster, R; Yanotti, CS; PAUL, P; Chanda, J; Gonçalves, BP; Horváth-Puhó, E; LAWN, JE; GBS Long-Term Outcomes LMIC Collaborative Group,; JIT, M;

2024

BMJ global health, (2024).9 5 10.1136/bmjgh-2023-014367.

The relationship between antibiotic use in humans and poultry and antibiotic resistance prevalence in humans: an ecological regression study of<i>Campylobacter</i>in the UK.

Emes, E; Guitian, J; KNIGHT, G; NAYLOR, N;

2024

medRxiv (2024). 10.1101/2024.01.10.24301092.

Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countries.

Prem, K; Cernuschi, T; Malvolti, S; Brisson, M; Jit, M;

2024

eClinicalMedicine, (2024).74, 10.1016/j.eclinm.2024.102735.

Inferring the regional distribution of Visceral Leishmaniasis incidence from data at different spatial scales.

NIGHTINGALE, E; Subramanian, S; Schwarzer, A; Chapman, L; Jambulingam, P; Cameron, M; Brady, O; MEDLEY, G; Lucas, T;

2024

Research Square (2024). 10.21203/rs.3.rs-3914673/v1.

Importance of investing time and money in integrating large language model-based agents into outbreak analytics pipelines.

Van Hoek, AJ; FUNK, S; FLASCHE, S; QUILTY, BJ; Van Kleef, E; Camacho, A; KUCHARSKI, AJ;

2024

The Lancet. Microbe (2024). 10.1016/s2666-5247(24)00104-6.

The contribution of animal antibiotic use to antibiotic resistance in humans: Panel evidence from Denmark.

Emes, E; Belay, D; KNIGHT, G;

2024

medRxiv (2024). 10.1101/2024.01.10.24301091.

Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT).

CARLILE, O; BRIGGS, A; Henderson, AD; Butler-Cole, BF C; Tazare, J; TOMLINSON, LA; MARKS, M; JIT, M; Lin, L-Y; Bates, C; Parry, J; Bacon, SC J; Dillingham, I; Dennison, WA; COSTELLO, RE; Walker, AJ; Hulme, W; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; HERRETT, E; EGGO, RM;

2024

The Lancet Regional Health - Europe, (2024).40, 10.1016/j.lanepe.2024.100908.

Corrigendum to "Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024" [Vaccine 42(15) (2024) 3379-3383].

Lambach, P; Silal, S; Sbarra, AN; Koh, M; Aggarwal, R; Farooqui, HH; Flasche, S; Hogan, AB; Kim, S-Y; Leung, K; Moss, WJ; Munywoki, PK; Portnoy, A; Sheel, M; Wang, X-Y;

2024

Vaccine (2024). 10.1016/j.vaccine.2024.07.003.

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.

Feng, S; McLellan, J; Pidduck, N; Roberts, N; Higgins, JP; Choi, Y; Izu, A; JIT, M; Madhi, SA; Mulholland, K; Pollard, AJ; PROCTER, S; Temple, B; Voysey, M;

2024

Health technology assessment (Winchester, England), (2024).28 34 10.3310/ywha3079.